Carlyle Group's acquisition of bluebird bio for $3 per share offers a potential but unlikely $600 million sales milestone by ...

AstraZeneca has entered the “off-the-shelf” cell therapy space, penning a $1 billion deal to acquire EsoBiotec and its ...

bluebird's Board of Directors (the “bluebird ... analytical methods to understand the safety of our lentiviral vector technologies and drive the field of gene therapy forward.

Bluebird Bio (NASDAQ: BLUE) said its planned acquisition by two investment firms is, according to its board, “in the best interest of stockholders”—but enough of them felt otherwise on ...

Philip Gregory, chief scientific officer at bluebird, said the latest analysis showed that the integration site of the vector was in a gene called VAMP4. bluebird bio's Philip Gregory VAMP4 has no ...

bluebird stockholders to receive $3.00 per share ... analytical methods to understand the safety of our lentiviral vector technologies and drive the field of gene therapy forward.

Bluebird has said it hopes to have some data within the next few weeks that should explore the possibility of a causal link. That is concentrating on determining where the vector integrated into ...

Given the recent M&A activity associated with companies such as 2seventy Bio, and BlueBird, and considering Precision Biosciences low market cap ($40 million), I wouldn’t be surprised if the ...

Browse 2,600+ bluebird bird stock illustrations and vector graphics available royalty-free, or start a new search to explore more great stock images and vector art. Bird with nest design. Bird ...